Cahuzac Armelle, Scemama Claire, Mauget-Faÿsse Martine, Sahel José-Alain, Wolff Benjamin
From Fondation Ophtalmologique Adolphe de Rothschild, Paris - France.
Eur J Ophthalmol. 2016 Jan-Feb;26(1):36-43. doi: 10.5301/ejo.5000641. Epub 2015 Jul 2.
To describe clinical, angiographic, and tomographic features and the therapeutic management of patients with retinal arterial macroaneurysm (RAM).
Retrospective analysis of patients diagnosed with RAM between January 2011 and September 2014 in Professor Sahel's Department of Ophthalmology, Rothschild Foundation. Retinal arterial macroaneurysms were classified as hemorrhagic, exudative, or quiescent. Patient demographics and comorbidities were recorded. All patients underwent complete ophthalmologic examination including initial and final visual acuity (Early Treatment Diabetic Retinopathy Study chart), slit-lamp biomicroscopy, fundus examination, color and autofluorescence fundus imaging, fluorescein and indocyanine green angiography, and spectral-domain optical coherence tomography. Treatments were recorded.
Fourteen RAMs of 14 patients were included: 9 hemorrhagic and 5 exudative. The most severe clinical picture was associated with the hemorrhagic form. Exudative cases had a progressive onset and a better visual prognosis. Direct laser photocoagulation was performed in 4 cases, anti-vascular endothelial growth factor (VEGF) intravitreal injection in 4 cases, combined treatment (YAG laser + argon laser + anti-VEGF intravitreal injection) in 1 case, and 5 cases received no treatment.
Retinal arterial macroaneurysm management should be specialized and rapid. Multimodal imaging should be performed for classifying it, assessing its prognosis and determining the most suitable treatment.
描述视网膜动脉大动脉瘤(RAM)患者的临床、血管造影和断层扫描特征以及治疗管理。
对2011年1月至2014年9月在罗斯柴尔德基金会萨赫勒眼科教授科室诊断为RAM的患者进行回顾性分析。视网膜动脉大动脉瘤分为出血性、渗出性或静止性。记录患者的人口统计学和合并症。所有患者均接受了全面的眼科检查,包括初始和最终视力(糖尿病视网膜病变早期治疗研究图表)、裂隙灯生物显微镜检查、眼底检查、彩色和自发荧光眼底成像、荧光素和吲哚菁绿血管造影以及光谱域光学相干断层扫描。记录治疗情况。
纳入14例患者的14个RAM:9个出血性和5个渗出性。最严重的临床症状与出血形式相关。渗出性病例起病渐进,视力预后较好。4例进行了直接激光光凝,4例进行了抗血管内皮生长因子(VEGF)玻璃体内注射,1例进行了联合治疗(YAG激光+氩激光+抗VEGF玻璃体内注射),5例未接受治疗。
视网膜动脉大动脉瘤的管理应专业化且迅速。应进行多模态成像以对其进行分类、评估预后并确定最合适的治疗方法。